Loading insider details...
Beta
Latest Form 4 (Oct 15, 2026): Grant/Award of 38,000 IBIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | iBio, Inc. (IBIO) | Grant/Award | 38,000 | n/a |
| Nov 24, 2025 | iBio, Inc. (IBIO) | Grant/Award | 13,500 | n/a |
| Jan 13, 2025 | iBio, Inc. (IBIO) | Purchase | 18,382 | $50.0K |
| Nov 25, 2024 | iBio, Inc. (IBIO) | Grant/Award | 12,600 | n/a |
| Feb 17, 2024 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 10,625 | n/a |
| Nov 1, 2023 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 13,209 | n/a |
| May 1, 2023 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 42,500 | n/a |
| Feb 7, 2023 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 42,500 | n/a |
| Oct 31, 2022 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 5,000 | n/a |
| Jul 6, 2022 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 63,492 | $200.0K |